In vitro testing of antimicrobial agents

Seminars in Pediatric Infectious Diseases

Volumn 9, Issue 4, 1998, Pages 281-291

  Kiska, D L ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; OXACILLIN; PENICILLIN DERIVATIVE; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ENTEROCOCCUS; HAEMOPHILUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REVIEW; STANDARDIZATION; STREPTOCOCCUS PNEUMONIAE;

EID: 0031734585     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1045-1870(98)80017-4     Document Type: Article

References (111)

1. Approved standard M7-A4 National Committee for Clinical Laboratory Standards Fourth Edition Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically 1997 NCCLS Villanova, PA
2. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Disk Susceptibility Tests Sixth Edition Approved standard M2-A6 1997 NCCLS Villanova, PA
3. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Susceptibility Testing Eighth Informational Supplement M100-S8 1998 CCLS Villanova, PA
4. Hill GB Schalkowsky S Development and evaluation of the spiral gradient endpoint method for susceptibility testing of anaerobic gram-negative bacilli Rev Infect Dis 2 1990 s2090900
5. Visser MR Bogaards L Rozenberg-Arska M Comparison of the auto SCAN-W/A and Vitek Automicrobic systems for identification and susceptibility testing of bacteria Eur J Clin Microbiol Infect Dis 11 1992 979 984
6. Rittenhouse SF Miller LA Utrup LJ Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroSanc Walkaway for 9 antimicrobial agents Diagn Microbiol Infect Dis 26 1996 1 6
7. York MK Brooks GF Fiss EH Evaluation of the autoSCAN-W/A rapid system for identification and susceptibility testing of gramnegative fermentative bacilli J Clin Microbiol 30 1992 2903 2910
8. Kelly MT Leicester C Evaluation of the Autoscan Walkaway system for rapid identification and susceptibility testing of gramnegative bacilli J Clin Microbiol 30 1992 1568 1571
9. Basomb S Godsey JH Kangas M Rapid antimicrobial susceptibility testing of gram-positive cocci using Baxter MicroScan rapid fluorogenic panels and autoSCAN-W/A Pathol Biol 39 1991 466 470
10. Gosdsey JH Bascomb S Bonnette T Rapid antimicrobial susceptibility testing of gram-negative bacilli using Baxter MicroScan rapid fluorogenic panels and autoSCAN-W/A Pathol Biol 39 1991 461 465
11. Korgenski EK Daly JA Evaluation of the BIOMIC video reader for determining interpretive categories of isolates on the basis of disk diffusion susceptibility results J Clin Microbiol 36 1998 302 304
12. Murray BE The life and times of the enterococcus Clin Microbiol Rev 3 1990 46 65
13. Leclercq R Dutka-Malen S Brisson-Noel A Resistance of enterococci to aminoglycosides and glycopeptides Clin Infect Dis 15 1992 495 501
14. Swenson JM Ferraro MJ Sahm DF Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci J Clin Microbiol 33 1995 3008 3018
15. Free L Sahm DF Investigation of the reformulated Remel Synergy Quad plate for detection of high-level aminoglycoside and vancomycin resistance among enterococci J Clin Microbiol 33 1995 1643 1645
16. Nolte FS Williams JM Maher KL Evaluation of modified MicroSan screening tests for high-level aminoglycoside resistance in Enterococcus faecalis Amer J Clin Pathol 99 1993 286 288
17. Louie M Simor AE Szeto S Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis J Clin Microbiol 30 1992 41 45
18. Szeto S Louie M Low DE Comparison of the new MicroScan Pos MIC type 6 panel and AMS-Vitek gram positive susceptibility card (GPS-TA) for detection of high-level aminoglycoside resistance in Enterococcus species J Clin Microbiol 29 1991 1258 1259
19. Sahm DF Boonlayangoor S Iwen PC Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis J Clin Microbiol 29 1991 1934 1939
20. Weissman D Spargo J Wennersten C Detection of enterococcal high-level aminoglycoside resistance with MicroScan freezedried panels containing newly modified medium and Vitek grampositive susceptibility cards J Clin Microbiol 29 1991 1232 1235
21. Woods GL DiGiovanni B Levison M Evaluation of MicroScan rapid panels for detection of high-level aminoglycoside resistance in enterococci J Clin Microbiol 31 1993 2786 2787
22. Willey BM Kreiswirth BN Simor AE Detection of vancomycin resistance in Enterococcus species J Clin Microbiol 30 1992 1621 1624
23. Carlier C Courvalin P Emergence of 4′-4″-aminoglycoside nucleotidyltransferase in enterococci Antimicrob Agents Chemother 34 1990 1565 1569
24. Sahm DF Torres C Effects of medium and inoculum variations on screening for high-level aminoglycoside resistance in Enterococcus faecalis J Clin Microbiol 26 1988 250 256
25. Sahm DF Torres C High-content aminoglycoside disks for determining aminoglycoside-penicillin synergy agiants Enterococcus feaecalis J Clin Micobiol 26 1988 257 260
26. Shlaes DM Rice LB Bacterial resistance to the cyctic glycopeptides Trends Microbiol 2 1994 385 388
27. Toye B Shymanski J Bobrowska M Clinical and epidemiologic significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype) J Clin Microbiol 35 1997 3166 3170
28. Ruoff KL De la Maza L Murtagh MJ Species identities of enterococci isolated from clinical specimens J Clin Microbiol 28 1990 435 437
29. Facklam RR Collins MD Identification of Enterococcus species isolated from human infections by a conventional test scheme J Clin Microbiol 27 1989 731 734
30. Morris JG Shay DK Hebden JN Enterococci resistant to multiple antimicrobial agents Ann Intern Med 123 1995 250 259
31. Tenover FC Swenson JM O'Hara CM Ability of commerical and reference antimicrobial susceptibility testing methods to detect vancomycin resistancer in enterococci J Clin Microbiol 33 1995 1524 1527
32. Schulz JE Sahm DF Reliability of the E test for detection of ampicillin, vancomycin, and high-level aminoglycoside resistance in Enterococcus spp J Clin Microbiol 31 1993 3336 3339
33. Kohner PC Patel R Uhl JR Comparison of after dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp, to vancomycin J Clin Microbiol 35 1997 3258 3263
34. Endtz HP van den Braak N van Belkum A Comparison of eight methods to detect vancomycin resistance in enterococci J Clin Microbiol 36 1998 592 594
35. Sahm DF Olsen L In vitro detection of enterococcal vancomycin resistance Antimicrob Agents Chemother 34 1990 1846 1848
36. Huang MB Baker CN Banerjee S Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobcter jejune , and gram-negative bacteria resistant to antimicrobial agents J Clin Microbiol 30 1992 3243 3248
37. Tenover FC Tokars J Swenson J Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci J Clin Microbiol 31 1993 1695 1699
38. Iwen PC Kelly DM Linder J Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels J Clin Microbiol 34 1996 1779 1783
39. Swenson JM Clark NC Ferraro MJ Development of a standardized screening method for detection of vancomycinresistant enterococci J Clin Microbiol 32 1994 1700 1704
40. Van Horn KG Gedris CA Rodney KM Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci J Clin Microbiol 34 1996 2042 2044
41. Jorgensen JH McElmeel ML Tripy CW Comparison of inoculation methods for testing enterococci by using vancomycin screening agar J Clin Microbiol 34 1996 2841 2842
42. Edlund C Barkholt L Olsson-Liljequist B Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy Clin Infect Dis 25 1997 729 732
43. Silverman J Thai LA Perri MB Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci J Clin Microbiol 36 1998 830 832
44. Free L Sahm DF Detection of enterococcal vancomycin resistance by multiplex PCR Persing DH PCR Protocols for Emerging Infectious Diseases 1996 Amer Soc Microbiol Washington, DC 150 155
45. Sahm DF Free L Smith C Rapid characterization schemes for surveillance isolates of vancomycin-resistant enterococci J Clin Microbiol 35 1997 2026 2030
46. Bush LM Calmon J Cherney CL High-level penicillin resistance among isolates of enterococci Ann Intern Med 110 1989 515 520
47. Swenson JM Hill BC Thornsberry C Screening pneumococci for penicillin resistance J Clin Microbiol 24 1986 749 752
48. Jacobs MR Bajaksouzian Palavecino-Fasola EL Determination of penicillin MICs for Streptococcus pneumoniae by using a two-or three-disk diffusion procedure J Clin Microbiol 36 1998 179 183
49. (letter) Lopardo HA Lovadina L Rubeglio EA More about cefuroxime screening test for pneumococci J Clin Microbiol 33 1995 1044 1045
50. Barry AL Fuchs PC Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae J Clin Microbiol 34 1996 2609 2612
51. Friedland IR Shelton S McCracken GH Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test J Clin Microbiol 31 1993 1619 1621
52. (reply) Jorgensen JH More about cefuroxime screening test for pneumococci J Clin Microbiol 33 1995 1044 1045
53. Jorgensen JH Swenson JM Tenover FC Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae J Clin Microbiol 32 1994 2448 2459
54. Tenover FC Baker CN Swenson JM Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae J Clin Microbiol 34 1996 10 14
55. Nolte FS Metchock B Williams T Detection of penicillinresistant Streptococcus pneumoniae with commercially available broth microdilution panels J Clin Microbiol 33 1995 1804 1806
56. Kiska DL Kerr A Jones MC Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae J Clin Microbiol 33 1995 229 232
57. Krisher KK Linscott A Comparison of three commercial MIC systems, E test, Fastidious Antimicrobial Susceptibility panel, and FOX fastidious panel, for confirmation of pencillin and cephalosporin resistance in Streptococcus pneumoniae J Clin Microbiol 32 1994 2242 2245
58. Skulnick M Small GW Lo P Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone J Clin Microbiol 33 1995 2334 2337
59. Jorgensen JH McElmeel ML Crawford SA Evaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains recent clinical isolates J Clin Microbiol 36 1998 788 791
60. Lyon B Skurray R Antimicrobial resistance of Staphylococcus aureus : Genetic basis Microbiol Rev 51 1987 88 134
61. Knapp CC Ludwig MD Washington JA Evaluation of differential inoculum disk diffusion method and Vitek GPS-SA card for detection of oxacillin-resistant staphylococci J Clin Microbiol 32 1994 433 436
62. DeLancastre H Sa Figueiredo AM Urban C Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus Antimicrob Agents Chemother 35 1991 632 639
63. Woods GL LaTemple D Cruz G Evaluation of MicroScan rapid gram-positive panels for detection of oxacillin-resistant staphylococci J Clin Microbiol 32 1994 1058 1059
64. Skulnick M Simor AE Gregson D Evaluation of commercial and standard methodology for determination of oxacillin susceptibility in Staphylococcus aureus J Clin Microbiol 30 1992 1985 1988
65. Hussain Z Stoakes L Lannigan R Evaluation of screening and commercial methods for detection of methicillin resistance in coagulase-negative staphylococci J Clin Microbiol 36 1998 273 274
66. York MK Gibbs L Chehab F Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase-negative staphylococci J Clin Microbiol 34 1996 249 253
67. Frebourg NB Nouet D Lemee L Comparison of ATB Staph, rapid ATB Staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA J Clin Microbiol 36 1998 52 57
68. Murakami K Minamide W PCR identification of methicillin-resistant Staphylococcus Persing DH Smith TF Tenover FC Diagnostic Molecular Microbiology 1993 Amer Soc Microbiol Washington, DC 539 542
69. Unal S Werner K DeGirolami P Comparison of tests for detection of methicillin-resistant Staphylococcus aureus in a clinical microbiology laboratory Antimicrob Agents Chemother 38 1994 345 347
70. (abstr C-176) Della-Latta P Hosmer M Whittier S Comparison of Crystal MRSA ID system with conventional and molecular methods for detection of methicillin-resistant S. aureus Program and abstracts of the 96th American Society for Microbiology General Meeting 1996 Am Soc Microbiol New Orleans, LA
71. Chambers HF Archer G Matsuhashi M Low-level methicillin resistance in strains of Staphylococcus aureus Antimicrob Agents Chemother 33 1989 424 428
72. Sahm DF Streptococci and staphylococci: laboratory considerations for in vitro susceptibility testing Clin Microbiol Newsl 16 1994 9 14
73. Gerberding JL Miick C Liu HH Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus Antimicrob Agents Chemother 35 1991 2574 2579
74. Huang MB Gay TE Baker CN Two percent sodium chloride is requir for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods J Clin Microbiol 31 1993 2683 2688
75. Zambardi G Fleurette J Schito GG European multicentre evaluation of a commercial system for identification of methicillinresistant Staphylococcus aureus Eur J Clin Microbiol Infect Dis 15 1996 747 749
76. Knapp CC Ludwig MD Washington JA Evaluation of BBL Crystal MRSA ID system J Clin Microbiol 32 1994 2588 2589
77. Hussain-Qadri SM Ueno Y Imambaccus H Rapid detection of methicillin-resistance Staphylococcus aureus by Crystal MRSA ID system J Clin Microbiol 32 1994 1830 1832
78. Wallet F Roussel-Delvallez M Courcol RJ Choice of routine method for detecting methicillin-resistance in staphylococci J Antimicrob Chemother 37 1996 901 909
79. Dillard SC Waites KB Brookings ES Detection of oxacillin-resistance in Staphylococcus aureus by MicroScan MIC panels in comparison to four other methods Diagn Microbiol Infect Dis 24 1996 93 100
80. Ieven M Jansens H Ursi D Rapid detection of methicillin resistance in coagulase-negative staphylococci by commercially available fluorescence test J Clin Microbiol 33 1995 2183 2185
81. McDonald CL Maher WE Fass RJ Revised interpretation of oxacillin MICs for Staphylococcus epideridis based on mecA detection Antimicrob Agents Chemother 39 1995 982 984
82. Anonymous Reduced susceptibility of Staphylococcus aureus to vancomycin-Japan, 1996 MMWR 46 1997 624 626
83. Anonymous Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997 MMWR 46 1997 765 766
84. Tenover FC Lancaster MV Hill BC Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides J Clin Microbiol 36 1998 1020 1027
85. Doern GV Brueggemann AB Pierce G Antibiotic resistance among clinical isolated of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study Antimicrob Agents Chemother 41 1997 282 297
86. Jorgensen JH Doern GV Thornsberry C Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents Diagn Microbiol Infect Dis 9 1988 27 32
87. Fuchs P Barry AL Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid J Clin Microbiol 32 1994 2846 2850
88. Zerva L Biedenbach DJ Jones RN Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks J Clin Microbiol 34 1996 1970 1974
89. Giger O Mortensen JE Clark RB Comparison of five different susceptibility test methods for detecting antimicrobial resistance among Haemophilus influenzae isolates Diagn Microbiol Infect Dis 24 1996 145 153
90. Murray BE β-lactamase-producing enterococci Antimicrob Agents Chemother 36 1992 2355 2359
91. (abstr C-119) Steffee CH Morrell RM Wasilauskas BL Routine testing for beta-lactamase positive enterococci: Is it really necessary? A paradigm shift in the clinical detection of rare organsms Program and abstracts of the 95th American Society of Microbiology General Meeting 1995 Am Soc Microbiol Washington, DC
92. Jacoby GA Medeiros AA More extended-spectrum β-lactamases Antimicrob Agents Chemother 35 1991 1697 1704
93. Sirot D Extended-spectrum plasmid-mediated β-lactamases J Antimicrob Chemother 36 suppl A 1995 19 34
94. Philippon A Arlet G Lagrange PH Origin and impact of plasnid-mediated extended-spectrum beta-lactamases Eur J Clin Microbiol Infect Dis 13 1994 17 29
95. DuBois SK Marriott MS Amyes SGB TEM- and SHV-derived extended-spectrum β-lactamases: Relationship between selection, structure and function J Antimicrob Chemother 35 1995 7 22
96. Bush K Jacoby GA Medeiros AA A functional classification scheme for β-lactamases and its correlation with molecular structure Antimicrob Agents Chemother 39 1995 1211 1233
97. Jacoby GA Han P Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli J Clin Microbiol 34 1996 908 911
98. Vercauteren F Descheemaeker P Ieven M Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp . in a Belgian teaching hospital J Clin Microbiol 35 1997 2191 2197
99. Thomson KS Sanders CC Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests Antimicrob Agents Chemother 36 1992 1877 1882
100. Katsanis GP Spargo J Ferraro MJ Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases J Clin Microbiol 32 1994 691 696
101. Henquell C Chanal C Sirot D Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli Antimicrob Agents Chemother 39 1995 427 430
102. (abstr C-87) Thomson KS Improved detection of extended-spectrum β-lactamases (ESBLs) from disk diffusion susceptibility tests Program and abstracts of the 95th General Meeting of the American Society for Microbiology 1995 Am Soc Microb Washington, DC
103. Cormican MG Marshall SA Jones RN Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the E test ESBL screen J Clin Microbiol 34 1996 1880 1884
104. Nuesch-Inderbinen MT Hachler H Kayser FH Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test Eur J Clin Microbiol Infect Dis 15 1996 398 402
105. (abstr D-44) Sanders CC Washington JA Barry AL Assessment of the Vitek ESBL test Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy 1994 Am Soc Microbiol Washington, DC
106. Moland ES Thomson KS Extended-spectrum β-lactamases of Enterobacteriaceae J Antimicrob Chemother 33 1994 666 668
107. Mabilat C Goussard S PCR detection and identification of genes for extended-spectrum β-lactamases Persing DH Smith TF Tenover FC Diagnostic Molecular Microbiol 1993 Amer Soc Microbiol Washington, DC 553 559
108. Sanders WE Sanders CC Inducible β-lactamases: Clinical and epidemiologic implications for use of newer cephalosporins Rev Infect Dis 10 1988 830 838
109. Bauernfeind A Wagner S Jungwirth R A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins Antimicrob Agents Chemother 41 1997 2041 2046
110. Bauernfeind A Stemplinger I Jungwirth R Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance Antimicrob Agents Chemother 40 1996 221 224
111. Bauernfiend A Stemplinger I Jungwirth R Comparative characterization of the cephamcinase blaCMY-1 gene and its relationship with other beta-lactamase genes Antimicrob Agents Chemother 40 1996 1926 1930